CD274 and cancer: B7-H4 and PD-L1 (PD-1 ligand), as inhibitory immune checkpoints, are often exploited by cancer cells to evade immunosurveillance in OSCC 36 and have been proven to be prognostic biomarkers in OSCC 37, 38.